Chronic hypnotic use: deadly risks, doubtful benefit

被引:95
|
作者
Kripke, DF [1 ]
机构
[1] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA
基金
美国国家卫生研究院;
关键词
hypnotics; epidemiology; mortality; hazard; triazolam; zolpidem; flurazepam;
D O I
10.1053/smrv.1999.0076
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the United States, roughly 2/3 of all hypnotic prescriptions go to chronic users, who have taken hypnotics for an average of 5 years or move. Two large prospective epidemiological studies have shown that reported hypnotic rise, especially use 30 times per month, is associated with an excess hazard of death. Indeed, use of hypnotics 30 times per month is associated with a similar mortality hazard to smoking 1-2 packs of cigarettes per day. Moreover, the hypnotic user's wish to improve daytime function is usually unfulfilled. The preponderance of evidence is that hypnotics impair performance, cognition and memory, increase the risk of automobile accidents and fails and promote unfavourable changes in personality. Due to tolerance, the sleep-promoting effects of hypnotics appear to be lost with chronic use. With long-term use, there is little controlled evidence that hypnotics produce benefits of any sort. More study of long-term hypnotic effects by public agencies is needed, but available evidence weighs strongly against long-term prescribing (C) 2000 Harcourt Publishers Ltd.
引用
收藏
页码:5 / 20
页数:16
相关论文
共 50 条
  • [41] Hypnotic treatment of chronic pain
    Jensen, M
    Patterson, DR
    JOURNAL OF BEHAVIORAL MEDICINE, 2006, 29 (01) : 95 - 124
  • [42] Hypnotic Discontinuation in Chronic Insomnia
    Hintze, Jonathan P.
    Edinger, Jack D.
    SLEEP MEDICINE CLINICS, 2018, 13 (02) : 263 - +
  • [43] REDUCING SERUM-CHOLESTEROL - LOWER CHOLESTEROL OF DOUBTFUL BENEFIT TO ANYONE
    RAVNSKOV, U
    BRITISH MEDICAL JOURNAL, 1993, 307 (6896): : 125 - 125
  • [44] Chronic breathlessness: silent and deadly
    Currow, David C.
    Johnson, Miriam J.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2016, 10 (03) : 221 - 222
  • [45] Hypnotic Treatment of Chronic Pain
    Mark Jensen
    David R. Patterson
    Journal of Behavioral Medicine, 2006, 29 : 95 - 124
  • [46] CHRONIC HYPNOTIC EFFICACY OF ESTAZOLAM
    LAMPHERE, J
    ROEHRS, T
    ZORICK, F
    KOSHOREK, G
    ROTH, T
    DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1986, 12 (08) : 687 - 691
  • [47] Benefit and Use of Prebiotics in Patients With Chronic Kidney Disease
    Zirker, Lindsey
    JOURNAL OF RENAL NUTRITION, 2015, 25 (02) : E9 - E10
  • [48] The Risk and Benefit of Benzodiazepine Use in Patients with Chronic Pain
    Cheatle, Martin D.
    Shmuts, Rachel
    PAIN MEDICINE, 2015, 16 (02) : 219 - 221
  • [49] Risks associated with chronic PPI use - signal or noise?
    Kia, Leiila
    Kahrilas, Peter J.
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2016, 13 (05) : 253 - U15
  • [50] Risks associated with chronic PPI use — signal or noise?
    Leila Kia
    Peter J. Kahrilas
    Nature Reviews Gastroenterology & Hepatology, 2016, 13 : 253 - 254